SEC CIK 1181540
COTE KATHLEEN A
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| WDCview stock → | 41,027 | 2020-11-18 |
| VRSNview stock → | 29,125 | 2026-07-20 |
| ASURview stock → | 23,772 | 2006-07-13 |
Position History — VRSN
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — VRSN
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-20 | Grant / award | 900 | $0.00 | 29,125 |
| 2025-07-21 | Grant / award | 879 | $0.00 | 28,225 |
| 2025-02-18 | Open-market sale | 3,000 | $230.00 | 27,346 |
| 2024-07-22 | Grant / award | 1,408 | $0.00 | 30,346 |
| 2023-07-24 | Grant / award | 1,179 | $0.00 | 28,938 |
| 2023-05-03 | Open-market sale | 1,000 | $224.28 | 27,759 |
| 2023-02-21 | Open-market sale | 2,665 | $202.97 | 28,759 |
| 2022-07-25 | Grant / award | 1,377 | $0.00 | 31,424 |
| 2022-03-02 | Open-market sale | 2,500 | $217.70 | 30,047 |
| 2021-07-19 | Grant / award | 1,093 | $0.00 | 32,547 |
| 2021-04-26 | Open-market sale | 1,000 | $215.94 | 31,454 |
| 2021-03-04 | Open-market sale | 1,000 | $190.79 | 32,454 |
| 2020-07-20 | Grant / award | 1,203 | $0.00 | 33,454 |
| 2020-04-27 | Open-market sale | 2,000 | $214.72 | 32,251 |
| 2019-07-31 | Open-market sale | 1,000 | $214.58 | 34,251 |
| 2019-07-22 | Grant / award | 1,157 | $0.00 | 35,251 |
| 2019-04-30 | Open-market sale | 3,500 | $198.26 | 34,094 |
| 2018-11-05 | Open-market sale | 2,384 | $160.50 | 37,594 |
| 2018-07-24 | Grant / award | 1,684 | $0.00 | 39,978 |
| 2017-08-22 | Open-market sale | 1,500 | $99.94 | 38,294 |
| 2017-07-25 | Grant / award | 2,475 | $0.00 | 39,794 |
| 2016-11-01 | Open-market sale | 5,000 | $84.00 | 37,319 |
| 2016-07-26 | Grant / award | 2,977 | $0.00 | 42,319 |
| 2015-07-21 | Grant / award | 3,687 | $0.00 | 39,342 |
| 2015-03-03 | Option exercise (derivative) | 8,884 | $0.00 | 0 |
| 2015-03-03 | Option exercise | 8,884 | $32.28 | 35,655 |
| 2014-11-13 | Option exercise (derivative) | 3,546 | $0.00 | 0 |
| 2014-11-13 | Option exercise | 3,546 | $36.06 | 30,317 |
| 2014-11-13 | Open-market sale | 3,546 | $60.07 | 26,771 |
| 2014-07-22 | Grant / award | 4,840 | $0.00 | 26,771 |
| 2013-07-23 | Grant / award | 5,296 | $0.00 | 21,931 |
| 2012-08-03 | Open-market sale | 2,000 | $45.74 | 16,635.82 |
| 2012-07-27 | Open-market sale | 1,110 | $42.94 | 18,635.82 |
| 2012-07-24 | Grant / award | 5,744 | $0.00 | 19,745.82 |
| 2012-04-27 | Open-market sale | 1,100 | $40.35 | 14,001.82 |
| 2012-01-27 | Open-market sale | 1,110 | $36.87 | 15,101.82 |
| 2011-10-27 | Open-market sale | 1,110 | $31.30 | 16,211.82 |
| 2011-07-27 | Open-market sale | 1,296 | $33.55 | 17,321.82 |
| 2011-07-26 | Grant / award | 5,920 | $0.00 | 18,617.82 |
| 2011-05-18 | Grant / award | 138.96 | $0.00 | 12,697.82 |
| 2011-05-18 | Grant / award | 655 | $0.00 | 12,296.86 |
| 2011-05-18 | Grant / award | 262 | $0.00 | 12,558.86 |
| 2011-04-27 | Open-market sale | 1,296 | $37.14 | 11,641.86 |
| 2011-01-27 | Open-market sale | 1,296 | $32.84 | 12,937.86 |
| 2011-01-21 | Grant / award | 323 | $0.00 | 14,233.86 |
| 2011-01-21 | Grant / award | 809 | $0.00 | 13,910.86 |
| 2010-12-28 | Grant / award | 471.86 | $0.00 | 13,101.86 |
| 2010-10-27 | Open-market sale | 1,296 | $33.03 | 12,630 |
| 2010-08-04 | Open-market sale | 1,812 | $29.25 | 13,926 |
| 2010-07-26 | Grant / award | 6,908 | $0.00 | 15,738 |
| 2010-05-04 | Open-market sale | 1,813 | $27.38 | 8,830 |
| 2010-02-04 | Open-market sale | 1,812 | $23.01 | 10,643 |
| 2009-11-04 | Open-market sale | 1,813 | $22.97 | 12,455 |
| 2009-10-13 | Open-market sale | 581 | $23.70 | 14,268 |
| 2009-08-03 | Grant / award | 9,666 | $0.00 | 14,849 |
| 2008-11-24 | Open-market buy | 700 | $17.82 | 5,183 |
| 2008-08-04 | Grant / award (derivative) | 8,884 | $0.00 | 8,884 |
| 2008-08-04 | Grant / award | 3,097 | $0.00 | 4,483 |
| 2008-02-20 | Grant / award (derivative) | 3,546 | $0.00 | 3,546 |
| 2008-02-20 | Grant / award | 1,386 | $0.00 | 1,386 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.